110 related articles for article (PubMed ID: 19300322)
1. Five-year experience of human papillomavirus DNA and Papanicolaou test cotesting.
Castle PE; Fetterman B; Poitras N; Lorey T; Shaber R; Kinney W
Obstet Gynecol; 2009 Mar; 113(3):595-600. PubMed ID: 19300322
[TBL] [Abstract][Full Text] [Related]
2. Five-year risk of recurrence after treatment of CIN 2, CIN 3, or AIS: performance of HPV and Pap cotesting in posttreatment management.
Katki HA; Schiffman M; Castle PE; Fetterman B; Poitras NE; Lorey T; Cheung LC; Raine-Bennett T; Gage JC; Kinney WK
J Low Genit Tract Dis; 2013 Apr; 17(5 Suppl 1):S78-84. PubMed ID: 23519309
[TBL] [Abstract][Full Text] [Related]
3. Benchmarking CIN 3+ risk as the basis for incorporating HPV and Pap cotesting into cervical screening and management guidelines.
Katki HA; Schiffman M; Castle PE; Fetterman B; Poitras NE; Lorey T; Cheung LC; Raine-Bennett T; Gage JC; Kinney WK
J Low Genit Tract Dis; 2013 Apr; 17(5 Suppl 1):S28-35. PubMed ID: 23519302
[TBL] [Abstract][Full Text] [Related]
4. The age-specific relationships of abnormal cytology and human papillomavirus DNA results to the risk of cervical precancer and cancer.
Castle PE; Fetterman B; Thomas Cox J; Shaber R; Poitras N; Lorey T; Kinney W
Obstet Gynecol; 2010 Jul; 116(1):76-84. PubMed ID: 20567171
[TBL] [Abstract][Full Text] [Related]
5. Role of Screening History in Clinical Meaning and Optimal Management of Positive Cervical Screening Results.
Castle PE; Kinney WK; Xue X; Cheung LC; Gage JC; Poitras NE; Lorey TS; Katki HA; Wentzensen N; Schiffman M
J Natl Cancer Inst; 2019 Aug; 111(8):820-827. PubMed ID: 30576462
[TBL] [Abstract][Full Text] [Related]
6. Cervical cancer screening with both human papillomavirus and Papanicolaou testing vs Papanicolaou testing alone: what screening intervals are physicians recommending?
Saraiya M; Berkowitz Z; Yabroff KR; Wideroff L; Kobrin S; Benard V
Arch Intern Med; 2010 Jun; 170(11):977-85. PubMed ID: 20548011
[TBL] [Abstract][Full Text] [Related]
7. Relative Performance of HPV and Cytology Components of Cotesting in Cervical Screening.
Schiffman M; Kinney WK; Cheung LC; Gage JC; Fetterman B; Poitras NE; Lorey TS; Wentzensen N; Befano B; Schussler J; Katki HA; Castle PE
J Natl Cancer Inst; 2018 May; 110(5):501-508. PubMed ID: 29145648
[TBL] [Abstract][Full Text] [Related]
8. Age-specific 3-year cumulative risk of cervical cancer and high-grade dysplasia on biopsy in 9434 women who underwent HPV cytology cotesting.
Ge Y; Christensen PA; Luna E; Armylagos D; Xu J; Hsu JW; Zhou H; Schwartz MR; Mody DR
Cancer Cytopathol; 2019 Dec; 127(12):757-764. PubMed ID: 31589379
[TBL] [Abstract][Full Text] [Related]
9. Cervical Cancer Screening: Comparison of Conventional Pap Smear Test, Liquid-Based Cytology, and Human Papillomavirus Testing as Stand-alone or Cotesting Strategies.
Liang LA; Einzmann T; Franzen A; Schwarzer K; Schauberger G; Schriefer D; Radde K; Zeissig SR; Ikenberg H; Meijer CJLM; Kirkpatrick CJ; Kölbl H; Blettner M; Klug SJ
Cancer Epidemiol Biomarkers Prev; 2021 Mar; 30(3):474-484. PubMed ID: 33187968
[TBL] [Abstract][Full Text] [Related]
10. Uptake of HPV testing and extended cervical cancer screening intervals following cytology alone and Pap/HPV cotesting in women aged 30-65 years.
Silver MI; Rositch AF; Phelan-Emrick DF; Gravitt PE
Cancer Causes Control; 2018 Jan; 29(1):43-50. PubMed ID: 29124542
[TBL] [Abstract][Full Text] [Related]
11. Glandular Lesions of the Cervix in Clinical Practice: A Cytology, Histology, and Human Papillomavirus Correlation Study From 2 Institutions.
Miller RA; Mody DR; Tams KC; Thrall MJ
Arch Pathol Lab Med; 2015 Nov; 139(11):1431-6. PubMed ID: 25951104
[TBL] [Abstract][Full Text] [Related]
12. Comparison of cervical cancer screening results among 256,648 women in multiple clinical practices.
Blatt AJ; Kennedy R; Luff RD; Austin RM; Rabin DS
Cancer Cytopathol; 2015 May; 123(5):282-8. PubMed ID: 25864682
[TBL] [Abstract][Full Text] [Related]
13. The value of monitoring human papillomavirus DNA results for Papanicolaou tests diagnosed as atypical squamous cells of undetermined significance: a College of American Pathologists Q-Probes study of 68 institutions.
Tworek JA; Jones BA; Raab S; Clary KM; Walsh MK
Arch Pathol Lab Med; 2007 Oct; 131(10):1525-31. PubMed ID: 17922588
[TBL] [Abstract][Full Text] [Related]
14. Contributions of Liquid-Based (Papanicolaou) Cytology and Human Papillomavirus Testing in Cotesting for Detection of Cervical Cancer and Precancer in the United States.
Kaufman HW; Alagia DP; Chen Z; Onisko A; Austin RM
Am J Clin Pathol; 2020 Sep; 154(4):510-516. PubMed ID: 32637991
[TBL] [Abstract][Full Text] [Related]
15. The clinician's view: role of human papillomavirus testing in the American Society for Colposcopy and Cervical Pathology Guidelines for the management of abnormal cervical cytology and cervical cancer precursors.
Cox JT;
Arch Pathol Lab Med; 2003 Aug; 127(8):950-8. PubMed ID: 12952506
[TBL] [Abstract][Full Text] [Related]
16. Prevalence of human papillomavirus genotype among Moroccan women during a local screening program.
Alhamany Z; El Mzibri M; Kharbach A; Malihy A; Abouqal R; Jaddi H; Benomar A; Attaleb M; Lamalmi N; Cherradi N
J Infect Dev Ctries; 2010 Nov; 4(11):732-9. PubMed ID: 21252451
[TBL] [Abstract][Full Text] [Related]
17. Cervical cancer screening from Pap smear to human papillomavirus DNA testing.
Jin XW; Xu H
Compr Ther; 2001; 27(3):202-8. PubMed ID: 11569320
[TBL] [Abstract][Full Text] [Related]
18. Trends Over Time in Pap and Pap-HPV Cotesting for Cervical Cancer Screening.
MacLaughlin KL; Jacobson RM; Radecki Breitkopf C; Wilson PM; Jacobson DJ; Fan C; St Sauver JL; Rutten LJF
J Womens Health (Larchmt); 2019 Feb; 28(2):244-249. PubMed ID: 30614380
[TBL] [Abstract][Full Text] [Related]
19. Cervical cancer rates after the transition from annual Pap to 3-year HPV and Pap.
Dinkelspiel H; Fetterman B; Poitras N; Kinney W; Cox JT; Lorey T; Castle PE
J Low Genit Tract Dis; 2014 Jan; 18(1):57-60. PubMed ID: 24022057
[TBL] [Abstract][Full Text] [Related]
20. History of high-risk HPV and Pap test results in a large cohort of patients with invasive cervical carcinoma: experience from the largest women's hospital in China.
Tao X; Griffith CC; Zhou X; Wang Z; Yan Y; Li Z; Zhao C
Cancer Cytopathol; 2015 Jul; 123(7):421-7. PubMed ID: 25955972
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
